Abstract
Psoriasis is a chronic inflammatory disease affecting 3% of the US population (Armstrong et al., 2021). The negative effect of psoriasis on health-related QOL is similar to that of other serious chronic diseases (Rapp et al., 1999). Data on the QOL burden of psoriasis among non-White populations are limited. This study evaluated racial/ethnic differences in the effect of psoriasis on health-related QOL, as measured by the Dermatology Life Quality Index (DLQI), among North American patients with psoriasis enrolled in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
